used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others 2,3...
NOTE. Pharmacopoeias consider that one unit of vita- min D is contained in 25 nanograms of colecalciferol or ergocalciferol (i.e. 1 mg of colecalciferol or ergocal- ciferol is equivalent to 40 000 units of vitamin D as de- termined by bioassay in rats), but see below. Equivalence. ...
In embodiments, a container of a kit disclosed herein may comprise a septum, barrier, cap, or closure effective to prevent evaporation or aerosolization of the reagent. Such prevention of evaporation or aerosolization of the reagent may be effective to prevent reagent loss, e.g., over time, ...
(United States Pharmacopea grade), to make a solution, according to the invention, containing 300 mcg vitamin D per one mL of oil. This composition was bottled in a glass container closed with a Eurodropper cap, with an opening designed to dispense 30 drops per one mL of oil. A breast...
Vitamin D supplementation has been shown to reduce the incidence of acute respiratory infections in populations at risk. The COVID-19 pandemic has highlighted the importance of preventing viral infections in healthcare workers. The aim of this study was to assess the hypothesis that vitamin D3 sup...
In a cohort of community-living adults, increased risk of hospitalization for CAP was associated with serum 25(OH)D levels <37 nmol/L and for sepsis with serum 25(OH)D levels <50 nmol/L. This association was not observed for 25(OH)D <75 nmol/L, suggesting that 25(OH)D <37 nmol/...
While sCD40L has been the subject of investigation in various medical contexts, including cognitive aging [45], septic shock in the intensive care unit [46], gestational diabetes mellitus in pregnant women [47], and systemic atherosclerosis [48], its role in the realm of cancer remains relative...
Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP). J. Gastrointest. Liver Dis. 2016, 25, 175–181. 24. Lorvand Amiri, H.; Agah, S.; Mousavi, S.N.; Hosseini, A.F.; Shidfar, F. Regression of non-alcoholic fatty ...
(2). Infliximab and placebo vitamin D3 (Ifx + placeboVitD); (3). Placebo infliximab and vitamin D3 (placeboIfx + VitD); (4). Placebo infliximab and placebo vitamin D3 (placeboIfx + placeboVitD). Patients receiving vitamin D3 (Dekristol) received a bolus of 200,000 international unit...
Standard Error p 1.26 0 2 0.0002 3.09 0.0003 2.01 0.0237 3.09 0.578 2.46 0.6455 2.22 0 3.53 0.0001 5.43 0.0257 3.52 0.0075 5.43 0.6437 3.32 0.2026 1.77 0 2.83 0.0001 4.34 0.0002 2.82 0.1965 4.34 0.2132 3.45 0.2389 The vitamin B3 (niacin) content presented a similar trend (Figure 1c,d). ...